Ates Irali

BREAKING: The final draft of a U.S.-Iran agreement has reportedly been reached through Pakistani mediation and could be announced within hours, though reports have not been confirmed.

How the fuck can you hear about all these atrocities & still support the Islamic Republic?! How can you watch all this killing and stay silent, Europe and UN? Why, you clowns?! Are the Muslim Brotherhood & IRGC controlling you that badly!

BREAKING: Foreign holdings of US Treasuries surged +$200 billion in February, to a record $9.49 trillion. Of that total, $7.76 trillion, or 84%, consists of long-term Treasury securities, with the remainder held in short-term Treasury bills. Over the last 12 months, holdings have risen +$587 billion. Japan, the largest foreign holder, raised its stockpile by +$14 billion, to $1.24 trillion, the highest since February 2022. This marks Japan's 13th monthly purchase of the last 14 months, as Japanese institutions continue chasing higher yields overseas. The UK, the 2nd-largest holder, posted a +$17 billion increase, to $897 billion, the 2nd-highest on record. China, the 3rd-largest owner, trimmed its stockpile by -$1 billion, to $693 billion. Foreign demand for US debt remains strong.

“Ekonomi ne kadar kötü olursa olsun, herkesin günlük en az 5 bira içebilmesi ve 5 bira da ısmarlayabilmesi gerekir. Bunun altı sefalettir. Endekslere bunu da ekleyin.”

BREAKING: The S&P 500 officially hits a new record high, now up +11% since the March 30th low. That’s +$6 TRILLION in market cap in 12 trading days.

“Where are the blockchain servers located” … My house?

Premarket movers: Mag 7 stocks are all green (Meta +1.5%, Microsoft +1.6%, Alphabet +1.4%, Amazon +1.5%, Apple +0.8%, Nvidia +1.3%, Tesla +1%) Apellis Pharmaceuticals Inc. (APLS) soars 138% after Biogen Inc. agreed to acquire the company for $5.6 billion. Centessa Pharmaceuticals (CNTA) rises 48% after Eli Lilly & Co. agreed to buy the sleep drug maker in a deal worth up to $7.8 billion. FactSet Research Systems (FDS) gains 6% after the financial data company boosted its adjusted earnings-per-share forecast for the full year. It also reported adjusted EPS and revenue for the second quarter that beat expectations. McCormick (MCK) rises 1.8% after Unilever said talks to sell most of its food business to the maker of spices are advanced. McCormick reported earnings on Tuesday and made no mention of the Unilever deal. PepGen (PEPG) plunges 44% after the biotech gave clinical data from a mid-stage trial of its drug candidate for a type of muscle disease. Analysts say the data is mixed and Oppenheimer notes that the selloff might be overdone. Phreesia (PHR) tumbles 23% after the healthcare software company lowered its full-year revenue forecast far below the analyst consensus. At least four brokerages downgraded their rating on the stock. Scholar Rock (SRRK) rises 11% after the company resubmitted its biologics license application for apitegromab, a muscle-targeted therapy for children and adults with spinal muscular atrophy, to the US Food and Drug Administration. T1 Energy (TE) falls 17% after the solar equipment manufacturer reported a wider than expected fourth-quarter loss per share and higher-than-expected expenses.